Mira Pharmaceuticals (FRA:K6S) Other Operating Expense: €-0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:K6S Mira Pharmaceuticals Inc FRA:K6S
13 GF Score
Price €0.62
! 1 Warning Sign
View Full Analysis

What is Mira Pharmaceuticals Other Operating Expense?

Mira Pharmaceuticals FRA:K6S -4.15% 13 Other Operating Expense is €-0.00 Mil as of Jun. 2026. GuruFocus rates FRA:K6S with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Mira Pharmaceuticals's Other Operating Expense for the three months ended in Jun. 2026 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was €-0.00 Mil.

Mira Pharmaceuticals's quarterly Other Operating Expense declined from Dec. 2025 (€0.00 Mil) to Mar. 2026 (€-0.00 Mil) and declined from Mar. 2026 (€-0.00 Mil) to Jun. 2026 (€-0.00 Mil).

Mira Pharmaceuticals's annual Other Operating Expense declined from Dec. 2023 (€0.42 Mil) to Dec. 2024 (€-0.00 Mil) but then increased from Dec. 2024 (€-0.00 Mil) to Dec. 2025 (€0.00 Mil).

Mira Pharmaceuticals Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Mira Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mira Pharmaceuticals Other Operating Expense Chart

Mira Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
0.62 1.61 0.42 -0.00 0.00

Mira Pharmaceuticals Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.00 -0.00
FRA:K6S
13GF Score
Mira Pharmaceuticals Inc FRA:K6S
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mira Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of €-0.00 Mil mean?
Mira Pharmaceuticals (FRA:K6S) has a Other Operating Expense of €-0.00 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Mira Pharmaceuticals and its competitors.
Is Mira Pharmaceuticals' Other Operating Expense too high?
Mira Pharmaceuticals' current Other Operating Expense is €-0.00 Mil. Overall, Mira Pharmaceuticals has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Mira Pharmaceuticals' Other Operating Expense compare to NSRX and SCLX?
Mira Pharmaceuticals' Other Operating Expense of €-0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Mira Pharmaceuticals and its competitors. Mira Pharmaceuticals's current Other Operating Expense is €-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mira Pharmaceuticals stock overvalued right now?
Mira Pharmaceuticals (FRA:K6S) has a current Other Operating Expense of €-0.00 Mil. The current Other Operating Expense is €-0.00 Mil. Mira Pharmaceuticals' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Mira Pharmaceuticals (FRA:K6S), the current Other Operating Expense is €-0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mira Pharmaceuticals Business Description

Other Exchanges MIRA:USA
Address 1200 Brickell Avenue, Suite 1950 No. 1183, Miami, FL, USA, 33133
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
13GF Score

Get the complete analysis for FRA:K6S

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.62
Price